Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sandoz

Executive Summary

To establish an American Depositary Receipt program for its registered shares. Morgan Guaranty Trust Company will be the depository. Company characterizes the move as a "further step in broadening its international shareholder base". . . . Marion Merrell Dow's: Cardizem CD once-a-day diltiazem capsules for hypertension gains "approvable" status from FDA on Oct. 10; Cardizem Injectable approvable as of Oct. 4. MMD filed the NDA for Cardizem CD in February 1990 and for the NDA for I.V. diltiazem in October 1989. Plant inspections for the calcium channel blocker products are underway; labeling issues have been resolved for injectable Cardizem and negotiations are being completed for CD. . . .
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019888

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel